Skip to main content
Signal8

Rickey James Paul

SEC insider (Form 3/4/5 filer). CIK 0001606243. Chief Financial Officer at Braveheart Bio, Inc. (BRVE). 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in SAN FRANCISCO, CA.

Companies Rickey James Paul has filed insider reports for

  • Braveheart Bio, Inc. (BRVE): Officer, Chief Financial Officer
Rickey James Paul profile photo

Rickey James Paul

CIK: 0001606243

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Braveheart Bio, Inc. logo
BRVE

Braveheart Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Braveheart Bio, Inc. logo
    BRVE

    Braveheart Bio, Inc.

    Aug 7, 2026
    Purchase
    Direct
    27.8K shares at avg. $18.00$500K
  • Braveheart Bio, Inc. logo
    BRVE

    Braveheart Bio, Inc.

    Aug 5, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    300K shares-

1-2 of 2